Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 883 | 70 | 1,865 | 5,317 | 8,385 |
| Marketable Securities | N/A | N/A | N/A | N/A | 3,836 |
| Receivables | 1,201 | 870 | 318 | 1,110 | 1,278 |
| TOTAL | $2,166 | $1,083 | $2,359 | $6,574 | $13,841 |
| Non-Current Assets | |||||
| PPE Net | 14 | 22 | 11 | 34 | 42 |
| TOTAL | $14 | $22 | $11 | $34 | $42 |
| Total Assets | $2,180 | $1,105 | $2,370 | $6,607 | $13,882 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,307 | 5,419 | 86 | 76 | 65 |
| Accounts payable and accrued liabilities | 2,951 | 3,101 | 2,136 | 5,151 | 3,434 |
| TOTAL | $11,279 | $8,555 | $2,252 | $5,321 | $3,499 |
| Non-Current Liabilities | |||||
| Long Term Debt | 529 | 649 | 5,713 | 3,896 | 718 |
| Deferred Revenues | N/A | N/A | N/A | 94 | N/A |
| TOTAL | $529 | $649 | $5,713 | $3,896 | $718 |
| Total Liabilities | $11,808 | $9,203 | $7,966 | $9,216 | $4,217 |
| Shareholders' Equity | |||||
| Common Shares | 30,418 | 31,374 | 32,018 | 31,635 | 26,498 |
| Retained earnings | -51,544 | -51,219 | -49,409 | -44,732 | -23,458 |
| Other shareholders' equity | 847 | 2,205 | 6,944 | 6,488 | 4,691 |
| TOTAL | $-9,629 | $-8,099 | $-5,596 | $-2,609 | $9,665 |
| Total Liabilities And Equity | $2,180 | $1,105 | $2,370 | $6,607 | $13,882 |